FDA clears Contego Medical ’ s Paladin carotid balloon

Contego Medical said today that it won 510(k) clearance from the FDA for its Paladin carotid balloon with embolic protection. Raleigh, N.C.-based Contego said the Paladin device consists of an angioplasty balloon and a 40-micron filter for carotid stenting procedures. It won CE Mark approval in 2015 in the European Union, where it launched the following January. A post-market surveillance study of 106 patients showed a 0.9% risk of death, stroke and myocardial infarction at 30 days and zero procedural strokes, the company said. “We are thrilled to have achieved this milestone for the first of several devices Contego Medical intends to bring to the U.S. market,” founder &CEO Dr. Ravish Sachar said in prepared remarks. “The Paladin system utilizes our patented integrated embolic protection technology, aimed at providing superior performance while improving the safety profile of existing cardiovascular procedures. With the strength of our clinical data and the unique promise of our IEP technology, we look forward to positively impacting patient care and outcomes.” “Minor stroke continues to be the Achilles heel of carotid artery stenting, which occurs as a result of micro-embolization during the procedure,” added Dr. William Gray of Wynnewood, Pa.’s Main Line Health. “The Paladin system offers optimized micro-embolic protection during the most vulnerable aspects of the procedure, without additional device transitions ...
Source: Mass Device - Category: Medical Devices Authors: Tags: Cardiovascular Featured Food & Drug Administration (FDA) Contego Medical Source Type: news

Related Links:

Zoltan Kiss, Gy örgy Rokszin, Zsolt Abonyi-Tóth, György Jermendy, Péter Kempler, István Wittmann
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research
ConclusionIn patients suffering from severe CS due to AMI, the use of Impella is not associated with improved short-time survival but with higher complications rates compared to IABP and medical treatment. Better patient selection avoiding Impella implantation in futile situations or in possible lower risk CS might be necessary to elucidate possible advantages of Impella in future studies.
Source: Clinical Research in Cardiology - Category: Cardiology Source Type: research
Publication date: Available online 20 March 2019Source: Indian Heart JournalAuthor(s): Gaurang Nandkishor Vaidya, Abdur Khan, Shahab GhafghaziAbstractBackgroundMorphine is the recommended analgesic in acute myocardial infarction (AMI). This recommendation has come under scrutiny due to possible slow uptake of oral antiplatelet agents.ObjectiveWe performed a meta-analysis of all available studies in AMI patients treated with prasugrel or ticagrelor (P2Y12 inhibitors), that reported use of morphine prior to loading the antiplatelet agents to critically assess the safety of co-administration of morphine and the newer P2Y12 in...
Source: Indian Heart Journal - Category: Cardiology Source Type: research
As the cold and flu season continues this year, it is important to be aware that many of the most commonly used over-the-counter (OTC) remedies for congestion, aches, pains, and low-grade fevers contain medicines that can have harmful effects on the cardiovascular system. Chief among these medications are nonsteroidal anti-inflammatory drugs (NSAIDs) and decongestants. NSAIDs and your heart Certain NSAIDs are associated with a small increase in the relative risk for developing a heart attack, stroke, heart failure, atrial fibrillation, increased blood pressure, and blood clots. NSAIDs relieve pain and inflammation by inhib...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Cold and Flu Drugs and Supplements Health Heart Health Source Type: blogs
CONCLUSIONS: The experimental treatment strategy of one-month DAPT followed by 23 months of ticagrelor alone did not result in a significant reduction in the rates of site-reported POCE or NACE, when compared to the reference treatment. PMID: 30888959 [PubMed - as supplied by publisher]
Source: EuroIntervention - Category: Cardiovascular & Thoracic Surgery Tags: EuroIntervention Source Type: research
HIGH cholesterol can be caused by eating an unhealthy diet and increases the risk of serious health conditions. While eggs are associated with a healthy diet, a new study has linked them to high cholesterol consumption and suggested they can “significantly” increase the risk of a heart attack or stroke.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
This study compared outcomes using the ACC/AHA risk algorithm and the Framingham risk score (FRS) tool in The Heart Outcomes Prevention Evaluation (HOPE) 3 study.MethodsWe compared outcomes using the ACC/AHA algorithm and the FRS with those seen in HOPE-3, which randomized participants to 10mg rosuvastatin or placebo. First co-primary outcome was the composite of death from cardiovascular causes, nonfatal myocardial infarction or nonfatal stroke; second co-primary outcome additionally included heart failure, cardiac arrest and revascularization.ResultsRelative risks using risk scores were similar to those observed in the H...
Source: Canadian Journal of Cardiology - Category: Cardiology Source Type: research
Publication date: Available online 19 March 2019Source: Canadian Journal of CardiologyAuthor(s): Federico Fortuni, Gabriele Crimi, Filippo Angelini, Sergio Leonardi, Fabrizio D’Ascenzo, Marco Ferlini, Marco Rolando, Arturo Raisaro, Luigi Oltrona Visconti, Maurizio Ferrario, Massimiliano Gnecchi, Gaetano M. De FerrariAbstractBackgroundThe optimal strategy and timing of revascularization in hemodynamically stable patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease is unknown. We performed a systematic review and meta-analysis to explore the comparative efficacy and safety of early c...
Source: Canadian Journal of Cardiology - Category: Cardiology Source Type: research
The study suggests that the prescription fish oil pill, not to be confused with over-the-counter supplements, reduces the lifetime risk of dying from heart disease; having a non-fatal heart attack or stroke; or needing heart surgery or hospitalization for a heart complication.
Source: WebMD Health - Category: Consumer Health News Source Type: news
Raised blood pressure with age, hypertension, is a major downstream consequence of low-level biochemical damage and cellular dysfunction, converting it into high-level structural damage in the body and brain. Hypertension is an important proximate contributing cause of ultimately fatal age-related conditions of the cardiovascular system, kidneys, brain, and lungs, among others. Pressure damage in delicate tissues degrades function in many organs, particularly in the central nervous system where there is little to no regeneration capable of reversing that damage. More subtly, hypertension also causes heart muscles to enlarg...
Source: Fight Aging! - Category: Research Authors: Tags: Medicine, Biotech, Research Source Type: blogs
More News: Angioplasty | Baloon Angioplasty | Cardiology | Cardiovascular | Carotid Angioplasty | Heart | Heart Attack | Medical Devices | Peripheral Angioplasty | Stroke | Study